Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01757106Phase 2Completed
A Phase 2 trial of xenon in coronary artery disease (CAD), sponsored by UZ Leuven. Started Dec 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01757106.